... for spinal cord injury and other central nervous system disorders, such as demyelinating disease, stroke and Alzheimer's disease. A phase I trial of HuCNS-SC for infantile and late-infantile NCL has been initiated, following the March 2006 U.S. Food ...
http://www.citeulike.org/user/leonardcj/article/12268103
http://www.citeulike.org/user/leonardcj/article/12268103
No comments:
Post a Comment